Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
With more than 5 million fatalities and close to 300 million reported cases, COVID-19 is the
first documented pandemic due to a coronavirus that continues to be a major health …
first documented pandemic due to a coronavirus that continues to be a major health …
How to use COVID-19 antiviral drugs in patients with chronic kidney disease
Antiviral drugs such as Remdesivir (Veklury), Nirmatrelvir with Ritonavir (Paxlovid),
Azvudine, and Molnupiravir (Lagevrio) can reduce the risk for severe and fatal Coronavirus …
Azvudine, and Molnupiravir (Lagevrio) can reduce the risk for severe and fatal Coronavirus …
COVID‐19: An Overview of SARS‐CoV‐2 Variants—The Current Vaccines and Drug Development
The world is presently in crisis facing an outbreak of a health‐threatening microorganism
known as COVID‐19, responsible for causing uncommon viral pneumonia in humans. The …
known as COVID‐19, responsible for causing uncommon viral pneumonia in humans. The …
[HTML][HTML] Fuzzy logical algebra and study of the effectiveness of medications for COVID-19
A fuzzy logical algebra has diverse applications in various domains such as engineering,
economics, environment, medicine, and so on. However, the existing techniques in algebra …
economics, environment, medicine, and so on. However, the existing techniques in algebra …
Recent advances in small-molecular therapeutics for COVID-19
L Zhong, Z Zhao, X Peng, J Zou… - Precision Clinical …, 2022 - academic.oup.com
The COVID-19 pandemic poses a fundamental challenge to global health. Since the
outbreak of SARS-CoV-2, great efforts have been made to identify antiviral strategies and …
outbreak of SARS-CoV-2, great efforts have been made to identify antiviral strategies and …
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo
Atazanavir (ATV) has already been considered as a potential repurposing drug to 2019
coronavirus disease (COVID-19); however, there are controversial reports on its mechanism …
coronavirus disease (COVID-19); however, there are controversial reports on its mechanism …
Failed clinical trials on COVID-19 acute respiratory distress syndrome in hospitalized patients: common oversights and streamlining the development of clinically …
Introduction The coronavirus disease 2019 (COVID-19) pandemic has put a strain on global
healthcare systems. Despite admirable efforts to develop rapidly new pharmacotherapies …
healthcare systems. Despite admirable efforts to develop rapidly new pharmacotherapies …
Molecular insights of SARS-CoV-2 antivirals Administration: a balance between Safety profiles and Impact on Cardiovascular phenotypes
F Nappi, A Iervolino, SS Avtaar Singh - Biomedicines, 2022 - mdpi.com
The COVID-19 pandemic has resulted in a complex clinical challenge, caused by a novel
coronavirus, partially similar to previously known coronaviruses but with a different pattern of …
coronavirus, partially similar to previously known coronaviruses but with a different pattern of …
Drugs repurposing for SARS-CoV-2: New insight of COVID-19 druggability
Introduction The ongoing epidemic of severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) creates a massive panic worldwide due to the absence of effective …
(SARS-CoV-2) creates a massive panic worldwide due to the absence of effective …
[PDF][PDF] Efficacy and Safety of Atazanavir/Ritonavir versus Lopinavir/Ritonavir in Hospitalized COVID-19 Patients: A Randomized Clinical Trial
Background: While several antivirals have been considered among the candidate
repurposed drugs against SARS-CoV-2 infection, limited evidence exists on …
repurposed drugs against SARS-CoV-2 infection, limited evidence exists on …